FOLD
Amicus Therapeutics Inc
Price:  
13.70 
USD
Volume:  
2,707,219.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FOLD WACC - Weighted Average Cost of Capital

The WACC of Amicus Therapeutics Inc (FOLD) is 8.5%.

The Cost of Equity of Amicus Therapeutics Inc (FOLD) is 8.55%.
The Cost of Debt of Amicus Therapeutics Inc (FOLD) is 8.30%.

Range Selected
Cost of equity 7.00% - 10.10% 8.55%
Tax rate 0.60% - 1.50% 1.05%
Cost of debt 7.00% - 9.60% 8.30%
WACC 7.0% - 10.0% 8.5%
WACC

FOLD WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.62 0.87
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.00% 10.10%
Tax rate 0.60% 1.50%
Debt/Equity ratio 0.11 0.11
Cost of debt 7.00% 9.60%
After-tax WACC 7.0% 10.0%
Selected WACC 8.5%